Blueshift Asset Management »

Halozyme Therapeutics shares owned by Blueshift Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Blueshift Asset Management from 13F filings

Historical chart of Blueshift Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Blueshift Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $534k 8.3k 64.63
2025-06-30 $573k 11k 52.02
2021-09-30 $781k 19k 40.68
2021-06-30 $553k 12k 45.42
2021-03-31 $348k 8.3k 41.74
2019-12-31 $309k 17k 17.73